5-氯-α-甲基色胺
臨床資料 | |
---|---|
ATC碼 |
|
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 712-07-2 |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C11H13ClN2 |
摩爾質量 | 208.69 g·mol−1 |
3D模型(JSmol) | |
| |
|
5-氯-α-甲基色胺(5-氯-αMT,PAL-542)是一種與α-甲基色胺(αMT)相關的色胺衍生物,也是少數已知的特定血清素-多巴胺釋放劑(SDRA) 之一。[1][2]在動物研究中,它被發現可用於治療古柯鹼依賴。[2]它可以5-氯吲哚-3-甲醛為原料製得。[3]它在新加坡非法。[4]
參考文獻
- ^ Blough BE, Landavazo A, Partilla JS, et al. Alpha-ethyltryptamines as dual dopamine-serotonin releasers. Bioorganic & Medicinal Chemistry Letters. October 2014, 24 (19): 4754–8. PMC 4211607 . PMID 25193229. doi:10.1016/j.bmcl.2014.07.062.
- ^ 2.0 2.1 Banks ML, Bauer CT, Blough BE, et al. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys. Exp Clin Psychopharmacol. June 2014, 22 (3): 274–84. PMC 4067459 . PMID 24796848. doi:10.1037/a0036595.
- ^ Bruce E. Blough, Antonio Landavazo, John S. Partilla, Ann M. Decker, Kevin M. Page, Michael H. Baumann, Richard B. Rothman. Alpha-ethyltryptamines as dual dopamine–serotonin releasers. Bioorganic & Medicinal Chemistry Letters. 2014-10, 24 (19): 4754–4758 [2021-10-20]. PMC 4211607 . PMID 25193229. doi:10.1016/j.bmcl.2014.07.062. (原始內容存檔於2020-09-18) (英語).
- ^ Misuse of Drugs Act - Singapore Statutes Online. sso.agc.gov.sg. [2021-10-20]. (原始內容存檔於2021-04-17).